Atai Life Sciences N.V. (FRA:9VC)
Germany flag Germany · Delayed Price · Currency is EUR
1.888
-0.072 (-3.65%)
At close: Jun 27, 2025, 10:00 PM CET

Atai Life Sciences Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
3772162124131,075-
Upgrade
Market Cap Growth
-17.69%1.79%-48.71%-61.61%--
Upgrade
Enterprise Value
31815842151708-
Upgrade
Last Close Price
1.891.201.362.376.56-
Upgrade
PS Ratio
218.70724.60745.461893.6860.03-
Upgrade
PB Ratio
2.681.920.961.663.17-
Upgrade
P/TBV Ratio
2.741.980.971.693.25-
Upgrade
EV/Sales Ratio
200.02532.66147.41690.7939.54-
Upgrade
Debt / Equity Ratio
0.190.230.090.070.010.02
Upgrade
Asset Turnover
0.010.000.000.000.08-
Upgrade
Quick Ratio
3.502.559.0014.0117.567.99
Upgrade
Current Ratio
4.073.219.2214.4317.928.10
Upgrade
Return on Equity (ROE)
-79.43%-83.16%-17.21%-48.31%-72.40%-230.26%
Upgrade
Return on Assets (ROA)
-26.04%-27.54%-25.52%-25.09%-28.61%-66.32%
Upgrade
Return on Capital (ROIC)
-28.31%-30.48%-27.83%-26.84%-30.91%-73.14%
Upgrade
Earnings Yield
-36.57%-66.88%-17.18%-34.54%-13.72%-
Upgrade
FCF Yield
-19.32%-36.94%-36.05%-23.85%-5.27%-
Upgrade
Buyback Yield / Dilution
-3.07%-0.83%-2.00%-12.62%-48.64%-973.40%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.